Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6 Mexican cities with varied geographic conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Maria del Carmen Cano Salas, José Luis Miguel Reyes, Karen Sánchez Trejo, Erika del Carmen López Estrada, Jorge Salas Hernández, Monserrat Evelia Arroyo Rojas, Mauricio Castañeda Valdivia, Monserrat Escobar Preciado, Silvia Guzmán Vázquez, Sergio Ricardo García-García, Herman Soto Molina
Formato: Artículo
Lenguaje:English
Publicado: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2024-04-01
Colección:Revista Alergia México
Materias:
Adverse reaction to the drug
Acceso en línea:https://revistaalergia.mx/ojs/index.php/ram/article/view/1279

Ejemplares similares

Ejemplares similares